ARCHIVES

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

June 15, 2007

PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick

April 13, 1990

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996